[an error occurred while processing this directive]
en

Tumor suppressor role of chromatin-remodeling factor ARID1A

Expand
  • 1. Shenzhen Key Laboratory of Genitourinary Tumor, Shenzhen Second People’s Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen 518035, China; 2. Laboratory of Iron Metabolism and Molecular Biology, College of Life Science, Hebei Normal University, Shijiazhuang 050024, China; 3. Department of Biochemistry, Bethune Military Medical College, Shijiazhuang 050081, China

Received date: 2012-08-01

  Revised date: 2012-08-31

  Online published: 2013-03-25

Abstract

The mammalian SWI/SNF complex is one of ATP-dependent chromatin-remodeling complexes, which plays important roles in cell proliferation, differentiation, development and tumor suppression. ARID1A (AT-rich interactive domain-containing protein 1A) is a large subunit of SWI/SNF complex, and also an ARID family member with non- sequence-specific DNA binding activity. ARID1A is a tumor suppressor gene which is frequently mutated in many cancers, such as ovarian, bladder and gastric cancers. ARID1A can suppress cell proliferation through the up-regulation of p21 and the down-regulation of E2F-responsive genes. These findings on ARID1A and its role of tumor suppression con-tribute to understanding the mechanism of cancer development and developing new therapy for cancer.It is introduced in the review that ARID1A basic characteristic, related to cancer development, and biological role for full understanding of ARID1A

Cite this article

GUO Xiao-Qiang ZHANG Qiao-Xia HUANG Wei-Ren DUAN Xiang-Lin CAI Zhi-Ming . Tumor suppressor role of chromatin-remodeling factor ARID1A[J]. Hereditas(Beijing), 2013 , 35(3) : 255 -261 . DOI: 10.3724/SP.J.1005.2013.00255

References

[1] Maier VK, Chioda M, Becker PB. ATP-dependent chromatosome remodeling. Biol Chem, 2008, 389(4): 345-352.
[2] Clapier CR, Cairns BR. The biology of chromatin remodeling complexes. Annu Rev Biochem, 2009, 78(1): 273-304.
[3] Reisman D, Glaros S, Thompson EA. The SWI/SNF complex and cancer. Oncogene, 2009, 28(14): 1653-1668.
[4] Wang GG, Allis CD, Chi P. Chromatin remodeling and cancer, Part II: ATP-dependent chromatin remodeling. Trends Mol Med, 2007, 13(9): 373-380.
[5] Wiegand KC, Shah SP, Al-Agha OM, Zhao YJ, Tse K, Zeng T, Senz J, McConechy MK, Anglesio MS, Kalloger SE, Yang W, Heravi-Moussavi A, Giuliany R, Chow C, Fee J, Zayed A, Prentice L, Melnyk N, Turashvili G, Delaney AD, Madore J, Yip S, McPherson AW, Ha G, Bell L, Fereday S, Tam A, Galletta L, Tonin PN, Provencher D, Miller D, Jones SJ, Moore RA, Morin GB, Oloumi A, Boyd N, Aparicio SA, Shih IeM, Mes-Masson AM, Bow-tell DD, Hirst M, Gilks B, Marra MA, Huntsman DG. ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med, 2010, 363(16): 1532-1543.
[6] Jones S, Wang TL, Shih IM, Mao TL, Nakayama K, Roden R, Glas R, Slamon D, Diaz LA Jr, Vogelstein B, Kinzler KW, Velculescu VE, Papadopoulos N. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science, 2010, 330(6001): 228-231.
[7] Gui YT, Guo GW, Huang Y, Hu XD, Tang AF, Gao SJ, Wu RH, Chen C, Li XX, Zhou L, He MH, Li ZS, Sun XJ, Jia WL, Chen JN, Yang SM, Zhou FJ, Zhao XK, Wan SQ, Ye R, Liang CZ, Liu ZS, Huang PD, Liu CX, Jiang H, Wang Y, Zheng HC, Sun L, Liu XW, Jiang ZM, Feng DF, Chen J, Wu S, Zou J, Zhang ZF, Yang RL, Zhao J, Xu CJ, Yin WH, Guan ZC, Ye JX, Zhang H, Li JX, Kristiansen K, Nicker-son ML, Theodorescu D, Li YR, Zhang XQ, Li SG, Wang J, Yang HM, Wang J, Cai ZM. Frequent mutations of chro-matin remodeling genes in transitional cell carcinoma of the bladder. Nat Genet, 2011, 43(9): 875-878.
[8] Wang K, Kan JS, Yuen ST, Shi ST, Chu KM, Law S, Chan TL, Kan ZY, Chan ASY, Tsui WY, Lee SP, Ho SL, Chan AKW, Cheng GHW, Roberts PC, Rejto PA, Gibson NW, Pocalyko DJ, Mao M, Xu JC, Leung SY. Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer. Nat Genet, 2011, 43(12): 1219-1223.
[9] Takeuchi T, Chen BK, Qiu Y, Sonobe H, Ohtsuki Y. Mo-lecular cloning and expression of a novel human cDNA containing CAG repeats. Gene, 1997, 204(1-2): 71-77.
[10] Nie ZQ, Xue YT, Yang DF, Zhou S, Deroo BJ, Archer TK, Wang WD. A specificity and targeting subunit of a human SWI/SNF family-related chromatin-remodeling complex. Mol Cell Biol, 2000, 20(23): 8879-8888.
[11] Dallas PB, Pacchione S, Wilsker D, Bowrin V, Kobayashi R, Moran E. The human SWI-SNF complex protein p270 is an ARID family member with non-sequence-specific DNA binding activity. Mol Cell Biol, 2000, 20(9): 3137-3146.
[12] Kozmik Z, Machon O, Králová J, Kreslová J, Pa?es J, Vl?ek C. Characterization of mammalian orthologues of the Drosophila osa gene: cDNA cloning, expression, chromosomal localization, and direct physical interaction with Brahma chromatin-remodeling complex. Genomics, 2001, 73(2): 140-148.
[13] Wilsker D, Patsialou A, Zumbrun SD, Kim S, Chen Y, Dallas PB, Moran E. The DNA-binding properties of the ARID-containing subunits of yeast and mammalian SWI/ SNF complexes. Nucleic Acids Res, 2004, 32(4): 1345-1353.
[14] Patsialou A, Wilsker D, Moran E. DNA-binding properties of ARID family proteins. Nucleic Acids Res, 2005, 33(1): 66-80.
[15] Kim S, Zhang ZM, Upchurch S, Isern N, Chen Y. Struc-ture and DNA-binding sites of the SWI1 AT-rich interaction domain (ARID) suggest determinants for sequence- specific DNA recognition. J Biol Chem, 2004, 279(16): 16670-16676.
[16] Tang L, Nogales E, Ciferri C. Structure and function of SWI/SNF
Outlines

/